The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group

article


Haverkate, F.

Thompson, S.G.

Loo, J.C. van de
Baseline data are presented of the ECAT Angina Pectoris Study. Both plasminogen activator inhibitor and fibrinogen were positively associated with a number of cardiovascular risk factors such as smoking, body mass index, and also with the presence of coronary stenosis. Results indicate a role of the hemostatic system in the progress of coronary arteriosclerosis.
Chemicals/CAS: fibrinogen, 9001-32-5; plasminogen activator inhibitor, 105844-41-5; beta-Thromboglobulin; Fibrinogen, 9001-32-5; Plasminogen Inactivators; Platelet Factor 4, 37270-94-3; Tissue Plasminogen Activator, EC 3.4.21.68
Topics
















Angina Pectorisbeta-ThromboglobulinBlood Coagulation TestsCoronary ArteriosclerosisCross-Sectional StudiesFemaleFibrinogenFibrinolysisHemostasisHumanMaleMiddle AgePlasminogen InactivatorsPlatelet Factor 4Risk FactorsThrombosisTissue Plasminogen Activator
TNO Identifier
231710
Repository link
https://resolver.tno.nl/uuid:e32ddb76-da89-4012-8b65-f4ce440d9907
ISSN
10472797
Source
Annals of Epidemiology, 2(4), pp. 521-524.
Pages
521-524
Files
To receive the publication files, please send an e-mail request to TNO Repository.